Repligen

RGEN

RGEN Repligen NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    RGEN Chart
    See on advanced chart >

    About

    Repligen Corporation is a leading supplier of critical products used to manufacture biologic drugs. The company manufactures Protein A for major life science companies under long term supply agreements and also sell products directly to end users for use in...
    • Highlight
      A life sciences company focused on bioprocessing technology leadership
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      05/06/1986
    • Established Date
      Invalid Date
    • Full-time Employees
      2,025
    • Address
      41 Seyon Street Bldg. 1 Suite 100 Waltham MA 02453
    • Tel
      1-781-2500111
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-02-22 10:30:53